| pubmed-article:3898852 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3898852 | lifeskim:mentions | umls-concept:C0033808 | lld:lifeskim |
| pubmed-article:3898852 | lifeskim:mentions | umls-concept:C0014236 | lld:lifeskim |
| pubmed-article:3898852 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:3898852 | lifeskim:mentions | umls-concept:C0032790 | lld:lifeskim |
| pubmed-article:3898852 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:3898852 | lifeskim:mentions | umls-concept:C1136254 | lld:lifeskim |
| pubmed-article:3898852 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:3898852 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:3898852 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:3898852 | pubmed:dateCreated | 1985-10-21 | lld:pubmed |
| pubmed-article:3898852 | pubmed:abstractText | We compared subconjunctivally administered ceftazidime and BMY 28142, two third-generation cephalosporins, to a regimen of gentamicin and cefazolin for their ability to prevent experimental Pseudomonas postoperative endophthalmitis in rabbits. After extracapsular lens extraction, an inoculum of Pseudomonas was injected into the vitreous; one of the three antimicrobial regimens was then administered subconjunctivally. All 25 eyes treated with gentamicin and cefazolin become infected (P = 1). Two of 25 eyes treated with BMY 28142 became infected (P less than .001). None of the 25 eyes treated with ceftazidime became infected (P less than .001). | lld:pubmed |
| pubmed-article:3898852 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3898852 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3898852 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:3898852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3898852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3898852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3898852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3898852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3898852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3898852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3898852 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3898852 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:3898852 | pubmed:issn | 0002-9394 | lld:pubmed |
| pubmed-article:3898852 | pubmed:author | pubmed-author:BuxtonT BTB | lld:pubmed |
| pubmed-article:3898852 | pubmed:author | pubmed-author:RissingJ PJP | lld:pubmed |
| pubmed-article:3898852 | pubmed:author | pubmed-author:YannisR ARA | lld:pubmed |
| pubmed-article:3898852 | pubmed:author | pubmed-author:ShockleyR KRK | lld:pubmed |
| pubmed-article:3898852 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3898852 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:3898852 | pubmed:volume | 100 | lld:pubmed |
| pubmed-article:3898852 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3898852 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3898852 | pubmed:pagination | 404-7 | lld:pubmed |
| pubmed-article:3898852 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:meshHeading | pubmed-meshheading:3898852-... | lld:pubmed |
| pubmed-article:3898852 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:3898852 | pubmed:articleTitle | Multistrain comparison of three antimicrobial prophylaxis regimens in experimental postoperative Pseudomonas endophthalmitis. | lld:pubmed |
| pubmed-article:3898852 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3898852 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:3898852 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:3898852 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3898852 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3898852 | lld:pubmed |
